Our team is committed to providing ongoing support and guidance to help you navigate the challenges and triumphs during your weight loss journey
The FDA approved the Wegovy pill (oral semaglutide) in December 2025 and Foundayo (orforglipron) in April 2026, giving patients two oral options for the first time
Journal of Traditional and Complementary Medicine, 2 (4), 331-339
Whilst it does not directly treat diabetic neuropathy, its ability to improve glycaemic control and support weight loss may indirectly reduce the risk of developing nerve damage or slow its progression
And the consequence of this and were wrestling with this right now is that a larger study is needed to investigate this association, but without a diagnostic code, it is very difficult to appreciate how were going to find those cases
It slows gastric emptying so food moves through your stomach more gradually